Deploying robust hardware ecosystems across global clinical settings. Explore our core diagnostic systems, processing units, and integrated technological components.
Shenzhen BioX Medical Co., Ltd. is an industry-leading, specialized manufacturer and exporter dedicated to molecular diagnostic analysis systems, genetic testing solutions, and advanced clinical laboratory equipment. Established in 2017 in Shenzhen, China—a premier global powerhouse for biotechnology innovation and medical device engineering—we have consistently positioned ourselves at the forefront of in-vitro diagnostics (IVD).
Spanning an ultra-modern manufacturing facility covering more than 9,000 square meters and powered by a highly specialized workforce of over 200 employees, BioX Medical focuses on integrating sophisticated optical technologies, fluidics control, and intelligent algorithm systems. Our focus is to deliver reliable clinical-grade solutions to research centers, hospitals, and national public health surveillance systems worldwide.
Every system engineered at BioX Medical undergoes multi-stage verification to ensure absolute fidelity. We adhere strictly to ISO 13485:2016 quality management system certifications. By utilizing high-grade raw components, advanced testing tools, and rigorous environmental stress tests, we secure validation for every device before deployment, providing full traceablity and precision.
In the modern IVD market, global distributors and healthcare authorities face stringent demands. Our procurement processes address key risk vectors, ensuring seamless technology integration.
Modern clinical laboratories operate under heavy workload constraints. Sourcing managers actively seek modular systems that scale without compromising diagnostic precision. Our high-throughput real-time PCR platforms address this demand by accommodating multiple sample formats, decreasing laboratory turnaround time (TAT).
Procuring single-purpose diagnostic systems presents financial risks. The trend has shifted heavily toward multi-target biomarker systems capable of concurrently processing genetic markers, viral loads, oncological targets, and metabolic indices in a single run.
Connectivity is critical. Procurement directors prioritize instruments that sync natively with Laboratory Information Systems (LIS) via HL7 protocols. Our embedded IoT systems allow remote diagnostic telemetry, data validation, and seamless report generation.
Biomarker detection goes beyond single instruments. We design holistic, automated laboratory workflows that bridge sample acquisition with quantitative analytical execution.
Combining automated slide hybridization systems with dual-sided thermal distribution. Specially configured for FISH (Fluorescence In-Situ Hybridization) and IHC (Immunohistochemistry) workflows, optimizing genomic testing on tissue and cell samples.
Highly sensitive real-time PCR detection kits and instrumentation engineered for decentralized point-of-care (POCT) and central laboratory applications. Crucial for regional public health monitoring and rapid outbreak mitigation strategies.
We provide comprehensive manufacturing services, from custom chassis design to microfluidic assembly. Our cleanroom facilities construct tailor-made platforms for global diagnostic companies requiring precise component configurations.
To retain competitive leadership, BioX Medical is committed to a defined development roadmap. We focus on integrating smart sensors, artificial intelligence (AI), and high-resolution imaging platforms to push boundaries in clinical accuracy.
Integrating machine learning algorithms directly into the qPCR optical assembly to enable real-time baseline calculations. This diminishes standard variance and eliminates manual curve validation by laboratory personnel.
Transitioning from relative quantification to absolute target detection. This phase scales sub-nanoliter partitioning technologies to identify low-abundance tumor markers and pathogen loads with unmatched sensitivity.
Minimizing reagent waste and hands-on preparation time by deploying single-use cartridge chambers. These integrate extraction, amplification, and multi-wavelength reading on a unified microfluidic footprint.
BioX Medical provides comprehensive molecular diagnostic systems to partners across Europe, North America, Asia-Pacific, the Middle East, Latin America, and Africa. By combining high-performance manufacturing with efficient export logistics, we guarantee that clinical labs receive equipment on schedule and pre-calibrated to local standards.
Our localized networks provide seamless deployment. In countries across the EU and Americas, we operate in tandem with regional technical service hubs to minimize machine downtime and maintain continuity for clinical testing facilities.
Deploying medical diagnostics requires absolute compliance with national and regional legal standards. We ensure all shipments meet the necessary regulatory clearances for localized operations.
Instruments comply with European Union In-Vitro Diagnostic Regulation (EU 2017/746), assuring safety, performance, and risk management parameters.
We supply analytical equipment designed to facilitate FDA 510(k) applications, incorporating robust software cybersecurity and traceability requirements.
Engineered to meet China’s National Medical Products Administration guidelines, validating manufacturing reproducibility and clinical efficacy.
A visual tour of our modern 9,000 square meter production facility, design workshops, and optical assembly cleanrooms in Shenzhen.
Find answers to technical inquiries, delivery protocols, and system capabilities compiled by our engineering and logistics teams.
Integrating industrial-grade diagnostics, structural platforms, and precise clinical tools to optimize healthcare infrastructure globally.
BioX Medical
